TY  - GEN
AU  - Jett,J R
AU  - Maksymiuk,A W
AU  - Su,J Q
AU  - Mailliard,J A
AU  - Krook,J E
AU  - Tschetter,L K
AU  - Kardinal,C G
AU  - Twito,D I
AU  - Levitt,R
AU  - Gerstner,J B
TI  - Phase III trial of recombinant interferon gamma in complete responders with small-cell lung cancer
SN  - 0732-183X
PY  - 1994///1202
KW  - Adult
KW  - Aged
KW  - Blood Platelet Disorders
KW  - etiology
KW  - Carcinoma, Small Cell
KW  - mortality
KW  - Combined Modality Therapy
KW  - Dose-Response Relationship, Drug
KW  - Female
KW  - Humans
KW  - Interferon-gamma
KW  - adverse effects
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Patient Compliance
KW  - Platelet Count
KW  - Recombinant Proteins
KW  - Remission Induction
KW  - Survival Analysis
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1200/JCO.1994.12.11.2321
ER  -